Jefferies Upgrades Nuvation Bio to Buy, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Michael Yee upgrades Nuvation Bio (NUVB) from Hold to Buy and increases the price target from $1.4 to $10.
March 27, 2024 | 10:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies upgrades Nuvation Bio from Hold to Buy, with a price target increase from $1.4 to $10.
The upgrade from Hold to Buy by a reputable analyst, along with a significant increase in the price target, suggests a strong bullish outlook for Nuvation Bio. This is likely to attract investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100